- Oops!Something went wrong.Please try again later.
VCRA earnings call for the period ending June 30, 2021.
When it comes down to it, the greatest threat to your comfort in retirement is you.
Low-interest rates still got you down? Try this trio of dividend stocks on for size.
Elon Musk has built two industrial behemoths—Tesla and SpaceX—revolutionizing two industries. But that isn't all he has done to change industry.
Despite their stock prices taking a breather, these companies' operations seem to be unstoppable.
‘As long as all service staff are doing their job and getting paid an hourly wage, there is no reason to tip anyone.’
Chinese stocks have sold off en masse since the Spring, but is now the time for aggressive investors to go bargain-hunting in the Middle Kingdom? One indication could be the recent case of Meituan (OTC: MPNGF), the largest food delivery company in China, with businesses in daily deals, hotel bookings, community e-commerce, restaurant software, and grocery and drugstore delivery. On Oct. 8, China's State Administration for Market Regulation imposed a $534 million fine on Meituan -- a penalty for abusing its dominant market share in food delivery to force restaurants into exclusivity arrangements.
Warren Buffett is one of the greatest investors of our time. As a result of his long-term success, when he takes a position in a publicly traded stock, investors take notice. Read on to find out about a handful of stocks that Warren Buffett owns and determine for yourself whether they're also right for you to own.
The couple, who live in Lake Ozark, Mo., also receive $500 a month in child-care credits from the recent stimulus package. Together, their two traditional IRAs contain $285,000. In addition, Mr. Lynch has a small pension that will pay $325 a month when he turns 59½.
Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on five names. While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names. Nu Skin Enterprises Inc. recently was downgraded to Hold with a C+ rating by TheStreet's Quant Ratings.
With yields ranging from 7.7% to 10.4%, these dividend stocks can help maximize income-investors' returns.
General Electric's (NYSE: GE) upcoming earnings report is unlikely to produce any significant surprises on a headline basis. After all, management tends to give wide guidance ranges, and CEO Larry Culp spoke extensively about trading conditions at a conference in mid-September. Investors will be very interested in putting the pieces together to build a picture for 2022 and beyond.
Investors interested in electric vehicles have more choices today than ever before. Here are three good ones.
Burry's Scion Asset Management said in a regulatory filing in mid-May it had put options on 800,100 Tesla shares as of the end of the first quarter. Based on Tesla's closing price of $667.93 at the end of the first quarter, the value of that many shares would have been about $534 million. "No, it was a trade," Burry was quoted as saying in an email to CNBC on Friday, when asked whether he was still shorting Tesla.
How to decide whether to start collecting your retirement benefits at age 62, at your full retirement age (FRA), or even later.
Semiconductor returns might not be as solid in 2022 as they've been so far in 2021, so investors should stick to high-quality opportunities.
The stock market has been strong in 2021, but not for all companies. However, a select few are set up for big things next year.
Here's why they selected Regeneron Pharmaceuticals (NASDAQ: REGN), Vertex Pharmaceuticals (NASDAQ: VRTX), and Viatris (NASDAQ: VTRS). Prosper Junior Bakiny (Regeneron Pharmaceuticals): Shares of Regeneron dropped like a rock amid September's broad market declines.
Ocugen (NASDAQ: OCGN) shares took center stage earlier this year when the biotech joined the coronavirus vaccine race. The company partnered with India's Bharat Biotech to co-develop and co-commercialize Bharat's vaccine candidate -- Covaxin -- in the U.S. As a result, Ocugen shares soared as much as 763% in about six weeks. Now, some investors might be wondering if Ocugen will hang onto this positive momentum -- or whether the stock is heading for a crash.
With the underlying business gaining momentum, management may follow what other well-known names have done with their shares recently.
Even with minimal impact from the latest iPhone launch, the growing competitiveness of the wireless industry will be on full display when telecommunications companies start reporting quarterly results in the week ahead.